We’re looking forward to attending the American Society of Spine Radiology (ASSR) 2026 Annual Meeting, February 26-28, in New Orleans, LA. As we expand into...
Read MoreFollow Amber’s progress as we build clinical credibility for minimally invasive vertebral reconstruction through evidence generation, physician engagement, regulatory milestones, and platform expansion. Explore the latest updates on VCFix, Spinoza, clinical research, scientific publications, and upcoming opportunities to connect with the Amber team. Follow us on LinkedIn for more frequent updates.
CONFERENCES AND EVENTS
EVENT: Upcoming Friday Amber Implant will attend the German Spine Congress
Amber Implants will attend the DWG Annual Meeting in Wiesbaden! We’re looking forward to attending the 20th Annual Meeting of the Deutsche Wirbelsäulengesellschaft (DWG) on...
Read More
EVENT: Amber Implants will attend the NASS Annual Meeting in Denver
Amber Implants is heading to the 40th North American Spine Society Annual Meeting, Nov 14–16 in Denver. Our CEO, Vincent Gardès, and CTO, Mo Ahmadi,...
Read More
NEWS
Amber Implants Advances Pivotal European EXPAND Study of VCFix® Spinal System in Standalone Vertebral Reconstruction
Study evaluates VCFix® used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform. The Hague, Netherlands, June 17, 2026...
Read More
NEWS: Amber Implants Secures FDA 510(k) Clearance for VCFix® Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
The Hague, The Netherlands, 17 September 2025 – Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announced it has...
Read More
NEWS: Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical of VCFix® Spinal System
The Hague, The Netherlands, 3 June 2025 – Amber Implants, an innovative medical technology company developing next-generation implants for spinal injuries, today announces the completion...
Read More
NEWS: Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System
The Hague, Netherlands, 11 June 2024: Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces...
Read More
NEWS: Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures The Hague, Netherlands, 3 October 2023: Amber Implants, an innovative medical technology company developing next-generation implants...
Read More
News: Amber Implants receives ISO 13485:2016 certification.
The Hague, Netherlands, July 6, 2022: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces that it has...
Read More
PUBLICATIONS AND WHITE PAPERS
PUBLICATION | Evaluation of biocompatibility and osseointegration of multi-component TiAl6V4 titanium alloy implants
Orthopaedic implants are crucial for restoring the function, stability, and mobility of bones, and they can be made from materials such as metal, ceramic, polymer,...
Read More
White Paper: Bioplastics for 3D Printed Medical Implants
Polymers are particularly attractive in the medical device field due to their biocompatibility, mechanical properties comparable to those of the host tissues, and customizable manufacturing...
Read More
White Paper: Metallic Bio-Materials that can be used for 3D printed Medical Implants
Currently more than 70% of clinically used implants are made from metallic materials, such as stainless steel, cobalt chromium alloys, titanium alloys and others. However,...
Read More
White Paper: 5 Steps to set-up a solid quality management system for 3D printed implantable devices
Since medical devices directly affect the human body, safety is more important than non-medical industrial products. Each country has established standards and regulations to ensure...
Read More